Kidney cancer trials in Israel
8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Haifa, Kfar Saba, Petah Tikva, Ramat Gan
- Age
- 18 years and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - Phase 1/2Taking peopleSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Where
- Haifa, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years to 120 years
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07049926 · EU 2024-516437-12-00 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Beersheba, Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tsrifin
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Haifa, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Taking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Jerusalem, Petah Tikva, Ramat Gan
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - No phaseTaking peopleAssociation Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
- Where
- Tel Aviv
- Age
- 18 years and over
- People
- 300
- Run by
- Daniel Keizman
See details and how to joinNCT07485114 - Phase 1/2Taking peopleAutologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 50
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00722228 - Phase 1/2Not yet taking people in IsraelSingle-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.
- Where
- Petah Tikva
- Age
- 18 years to 100 years
- People
- 60
- Run by
- Rabin Medical Center
See details and how to joinNCT06896552